BACKGROUND AND OBJECTIVES: An intact endothelium is essential for adaptations between arterial vasomotor tone and shear stress (SS), i.e., flow-mediated vasodilation (FMD). Endothelial dysfunction occurs in hypertension, cardiac insufficiency, diabetes, atherosclerosis, and in end-stage renal disease (ESRD) patients, whose renal failure is associated with many of those cardiovascular diseases (CVD). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using a progressive hand-warming protocol and repeated measures ANOVA, we analyzed SS-mediated increase of brachial artery diameter (ΔBA) in 22 healthy controls, 18 CVD-negative ESRD patients (ESRD-CVD(-)), and 17 CVD-positive ESRD patients (ESRD-CVD(+)) to analyze the role of uremia versus CVD on FMD. RESULTS: Hand-warming increased SS (P < 0.001) and ΔBA (P < 0.001). Negative interactions were observed between ΔBA and ESRD (P < 0.001), and between ΔBA and CVD(+) (P < 0.02), but there was no interaction between ESRD and CVD(+) (P = 0.69). For low and mild SS increases, ESRD-CVD(-) patients were characterized by similar ΔBA as controls, but it was lower than controls at higher SS (P < 0.01). In ESRD-CVD(+) patients, brachial artery diameter did not respond to mild and moderate SS increases, and showed "paradoxical" vasoconstriction at higher SS (P < 0.05). In ESRD, a positive and independent interaction was observed between ΔBA and 25(OH) vitamin D(3) insufficiency (≤15 μg/L; P < 0.02). CONCLUSIONS: These observations indicate that, independently of each other, ESRD and CVD(+) history are associated with endothelial dysfunction. They also suggest the importance of considering the relationships between SS and endothelial function in different clinical conditions.
BACKGROUND AND OBJECTIVES: An intact endothelium is essential for adaptations between arterial vasomotor tone and shear stress (SS), i.e., flow-mediated vasodilation (FMD). Endothelial dysfunction occurs in hypertension, cardiac insufficiency, diabetes, atherosclerosis, and in end-stage renal disease (ESRD) patients, whose renal failure is associated with many of those cardiovascular diseases (CVD). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using a progressive hand-warming protocol and repeated measures ANOVA, we analyzed SS-mediated increase of brachial artery diameter (ΔBA) in 22 healthy controls, 18 CVD-negative ESRDpatients (ESRD-CVD(-)), and 17 CVD-positive ESRDpatients (ESRD-CVD(+)) to analyze the role of uremia versus CVD on FMD. RESULTS: Hand-warming increased SS (P < 0.001) and ΔBA (P < 0.001). Negative interactions were observed between ΔBA and ESRD (P < 0.001), and between ΔBA and CVD(+) (P < 0.02), but there was no interaction between ESRD and CVD(+) (P = 0.69). For low and mild SS increases, ESRD-CVD(-) patients were characterized by similar ΔBA as controls, but it was lower than controls at higher SS (P < 0.01). In ESRD-CVD(+) patients, brachial artery diameter did not respond to mild and moderate SS increases, and showed "paradoxical" vasoconstriction at higher SS (P < 0.05). In ESRD, a positive and independent interaction was observed between ΔBA and 25(OH) vitamin D(3) insufficiency (≤15 μg/L; P < 0.02). CONCLUSIONS: These observations indicate that, independently of each other, ESRD and CVD(+) history are associated with endothelial dysfunction. They also suggest the importance of considering the relationships between SS and endothelial function in different clinical conditions.
Authors: S K Samijo; R Barkhuysen; J M Willigers; K M L Leunissen; L A F Ledoux; P J E H M Kitslaar; A P G Hoeks Journal: Nephron Date: 2002 Impact factor: 2.847
Authors: R Joannides; C Bizet-Nafeh; A Costentin; M Iacob; G Derumeaux; A Cribier; C Thuillez Journal: Hypertension Date: 2001-12-01 Impact factor: 10.190
Authors: M J Mullen; R K Kharbanda; J Cross; A E Donald; M Taylor; P Vallance; J E Deanfield; R J MacAllister Journal: Circ Res Date: 2001-02-02 Impact factor: 17.367
Authors: C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger Journal: Lancet Date: 2001 Dec 22-29 Impact factor: 79.321
Authors: Kristen L Jablonski; Michel Chonchol; Gary L Pierce; Ashley E Walker; Douglas R Seals Journal: Hypertension Date: 2010-11-29 Impact factor: 10.190
Authors: Thomas Quaschning; Frank Ruschitzka; Thomas Stallmach; Sidney Shaw; Henning Morawietz; Winfried Goettsch; Matthias Hermann; Torsten Slowinski; Franz Theuring; Berthold Hocher; Thomas F Lüscher; Max Gassmann Journal: FASEB J Date: 2002-12-18 Impact factor: 5.191
Authors: Tienush Rassaf; Christos Rammos; Ulrike B Hendgen-Cotta; Christian Heiss; Werner Kleophas; Frank Dellanna; Jürgen Floege; Gerd R Hetzel; Malte Kelm Journal: Clin J Am Soc Nephrol Date: 2015-12-17 Impact factor: 8.237
Authors: Christian Ott; Ulrike Raff; Markus P Schneider; Stephanie I Titze; Roland E Schmieder Journal: Clin Res Cardiol Date: 2012-12-21 Impact factor: 5.460
Authors: Jennifer M MacRae; Sofia Ahmed; Brenda Hemmelgarn; Yichun Sun; Billie-Jean Martin; Idan Roifman; Todd Anderson Journal: Can J Kidney Health Dis Date: 2015-05-04